These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31563809)

  • 1. Enzyme-encapsulating polymeric nanoparticles: A potential adjunctive therapy in Pseudomonas aeruginosa biofilm-associated infection treatment.
    Han C; Goodwine J; Romero N; Steck KS; Sauer K; Doiron A
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110512. PubMed ID: 31563809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved effect of amikacin-loaded poly(D,L-lactide-co-glycolide) nanoparticles against planktonic and biofilm cells of Pseudomonas aeruginosa.
    Sabaeifard P; Abdi-Ali A; Gamazo C; Irache JM; Soudi MR
    J Med Microbiol; 2017 Mar; 66(2):137-148. PubMed ID: 28260589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing nanoparticles for improving anti-biofilm effects of azithromycin: A head-to-head comparison of modified hyaluronic acid nanogels and coated poly (lactic-co-glycolic acid) nanoparticles.
    Kłodzińska SN; Wan F; Jumaa H; Sternberg C; Rades T; Nielsen HM
    J Colloid Interface Sci; 2019 Nov; 555():595-606. PubMed ID: 31404843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyruvate-depleting conditions induce biofilm dispersion and enhance the efficacy of antibiotics in killing biofilms in vitro and in vivo.
    Goodwine J; Gil J; Doiron A; Valdes J; Solis M; Higa A; Davis S; Sauer K
    Sci Rep; 2019 Mar; 9(1):3763. PubMed ID: 30842579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encapsulation of Red Propolis in Polymer Nanoparticles for the Destruction of Pathogenic Biofilms.
    de Mélo Silva IS; do Amorim Costa Gaspar LM; Rocha AMO; da Costa LP; Tada DB; Franceschi E; Padilha FF
    AAPS PharmSciTech; 2020 Jan; 21(2):49. PubMed ID: 31900606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasmall TPGS-PLGA Hybrid Nanoparticles for Site-Specific Delivery of Antibiotics into
    Wan F; Bohr SS; Kłodzińska SN; Jumaa H; Huang Z; Nylander T; Thygesen MB; Sørensen KK; Jensen KJ; Sternberg C; Hatzakis N; Mørck Nielsen H
    ACS Appl Mater Interfaces; 2020 Jan; 12(1):380-389. PubMed ID: 31804792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection.
    Abdelghany SM; Quinn DJ; Ingram RJ; Gilmore BF; Donnelly RF; Taggart CC; Scott CJ
    Int J Nanomedicine; 2012; 7():4053-63. PubMed ID: 22915848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.
    Baelo A; Levato R; Julián E; Crespo A; Astola J; Gavaldà J; Engel E; Mateos-Timoneda MA; Torrents E
    J Control Release; 2015 Jul; 209():150-8. PubMed ID: 25913364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of ciprofloxacin complex loaded PLGA nanoparticles for pulmonary treatment of cystic fibrosis infections: Design of experiments approach.
    Günday Türeli N; Türeli AE; Schneider M
    Int J Pharm; 2016 Dec; 515(1-2):343-351. PubMed ID: 27744035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound-Activatable Phase-Shift Nanoparticle as a Targeting Antibacterial Agent for Efficient Eradication of
    Xin L; Zhang C; Chen J; Jiang Y; Liu Y; Jin P; Wang X; Wang G; Huang P
    ACS Appl Mater Interfaces; 2022 Oct; 14(42):47420-47431. PubMed ID: 36222290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates.
    Shaaban MI; Shaker MA; Mady FM
    J Nanobiotechnology; 2017 Apr; 15(1):29. PubMed ID: 28399890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
    Howlin RP; Cathie K; Hall-Stoodley L; Cornelius V; Duignan C; Allan RN; Fernandez BO; Barraud N; Bruce KD; Jefferies J; Kelso M; Kjelleberg S; Rice SA; Rogers GB; Pink S; Smith C; Sukhtankar PS; Salib R; Legg J; Carroll M; Daniels T; Feelisch M; Stoodley P; Clarke SC; Connett G; Faust SN; Webb JS
    Mol Ther; 2017 Sep; 25(9):2104-2116. PubMed ID: 28750737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual bioresponsive antibiotic and quorum sensing inhibitor combination nanoparticles for treatment of Pseudomonas aeruginosa biofilms in vitro and ex vivo.
    Singh N; Romero M; Travanut A; Monteiro PF; Jordana-Lluch E; Hardie KR; Williams P; Alexander MR; Alexander C
    Biomater Sci; 2019 Sep; 7(10):4099-4111. PubMed ID: 31355397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro evaluation of a ciprofloxacin- and ivacaftor-coated sinus stent against Pseudomonas aeruginosa biofilms.
    Cho DY; Lim DJ; Mackey C; Weeks CG; Garcia JAP; Skinner D; Zhang S; McCormick J; Woodworth BA
    Int Forum Allergy Rhinol; 2019 May; 9(5):486-492. PubMed ID: 30702211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyester-based particles to overcome the obstacles of mucus and biofilms in the lung for tobramycin application under static and dynamic fluidic conditions.
    Ernst J; Klinger-Strobel M; Arnold K; Thamm J; Hartung A; Pletz MW; Makarewicz O; Fischer D
    Eur J Pharm Biopharm; 2018 Oct; 131():120-129. PubMed ID: 30063969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles.
    Lababidi N; Montefusco-Pereira CV; de Souza Carvalho-Wodarz C; Lehr CM; Schneider M
    Eur J Pharm Biopharm; 2020 Dec; 157():200-210. PubMed ID: 33222771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti biofilm effect of dihydromyricetin-loaded nanocapsules on urinary catheter infected by Pseudomonas aeruginosa.
    Dalcin AJF; Santos CG; Gündel SS; Roggia I; Raffin RP; Ourique AF; Santos RCV; Gomes P
    Colloids Surf B Biointerfaces; 2017 Aug; 156():282-291. PubMed ID: 28544960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.